Little J, Alling D W, Asofsky R
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.
J Immunol. 1993 Mar 15;150(6):2129-38.
Murine B lymphocyte clones have proven to be useful models to study aspects of B lymphocyte growth and development. It had been previously shown that induction of TH2.2 (B lymphoma X B lymphocyte) with LPS resulted in differentiation into IgM-secreting cells (a feature similar to other B cells lines such as BCL1), and secretion of granulocyte-macrophage-CSF. Many transformed and nontransformed lines (including TH2.2) have been shown to generate progeny heterogenous in size and secretion of product when exposed to mitogen. We extend this study to demonstrate heterogeneity in secretion of IgM, granulocyte-macrophage-CSF, IL-3, and IL-6 in LPS-induced TH2.2. Clones generated by limiting dilution were heterogenous with respect to size, type, and quantity of product secreted. Microscopic clones ranged from 10 to about 1000 cells in size and could not be grown further; the majority secreted one product (mainly IgM). These clones were very efficient secretors of IgM and probably consist mainly of terminal-secreting cells. Microscopic clones secreting cytokine were also efficient producers. Visible clones from LPS-induced cultures grew to the same size as uninduced clones and were often restricted in secretion of products. Although the majority secreted three of four products (52%), many secreted IgM only or IgM and one cytokine. Although there was a strong tendency for clones to secrete multiple products, almost every secretory phenotype could be found. Amounts of different products secreted were not correlated, suggesting an additional level of independent control of this variable. Restriction of secretion was not due to genetic variation because visible clones originally restricted in secretion almost always produced all products when expanded and retested. These findings indicate that cells of TH2.2 were heterogeneous with respect to growth and secretion in the presence of LPS and were individually programmed for differentiative responses. The programming of cells was not permanent, but subject to dynamic change.
事实证明,小鼠B淋巴细胞克隆是研究B淋巴细胞生长和发育方面的有用模型。先前已经表明,用脂多糖诱导TH2.2(B淋巴瘤X B淋巴细胞)可导致其分化为分泌IgM的细胞(这一特征与其他B细胞系如BCL1相似),并分泌粒细胞-巨噬细胞集落刺激因子。许多转化和未转化的细胞系(包括TH2.2)已被证明在接触有丝分裂原时会产生大小和产物分泌各异的子代细胞。我们扩展了这项研究,以证明在脂多糖诱导的TH2.2中,IgM、粒细胞-巨噬细胞集落刺激因子、白细胞介素-3和白细胞介素-6的分泌存在异质性。通过有限稀释产生的克隆在大小、类型和分泌产物的数量方面存在异质性。显微镜下的克隆大小从10个细胞到约1000个细胞不等,无法进一步生长;大多数克隆分泌一种产物(主要是IgM)。这些克隆是非常高效的IgM分泌者,可能主要由终末分泌细胞组成。分泌细胞因子的显微镜下克隆也是高效的生产者。脂多糖诱导培养物中的可见克隆生长到与未诱导克隆相同的大小,并且其产物分泌通常受到限制。虽然大多数克隆分泌四种产物中的三种(52%),但许多克隆只分泌IgM或IgM和一种细胞因子。尽管克隆有强烈的分泌多种产物的倾向,但几乎可以找到每种分泌表型。不同产物的分泌量不相关,这表明对这一变量存在额外的独立控制水平。分泌受限并非由于基因变异,因为最初分泌受限的可见克隆在扩增并重新测试时几乎总是能产生所有产物。这些发现表明,在脂多糖存在的情况下,TH2.2细胞在生长和分泌方面是异质的,并且各自被编程以进行分化反应。细胞的编程不是永久性的,而是会发生动态变化。